The diagnosis of non-small cell lung cancer in the molecular era
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Link
http://www.nature.com/articles/s41379-018-0156-x.pdf
Reference47 articles.
1. Siegel R, Naishadham D, Jemal A. Cancer statisitcs, 2013. CA Cancer J Clin. 2013;63:11–20.
2. Vachani A, Sequist LV, Spira A. The shifting landscape for lung cancer: past, present, and future. Am J Respir Crit Care Med. 2017;195:1150–60.
3. Aberle DR, Berg CD, Adams AM. et al. Reduced lung-cancer mortality with low-dose computed tomographic screen. N Engl J Med. 2011;365:395–409.
4. Socinski MA, Evans T, Gettinger S. Treatment of stage IV non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e341S–68.
5. Lindeman NI, Cagle PT, Aisner DL, et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Thorac Oncol. 2018;13:323–58.
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Habitat-Based Radiomics for Predicting EGFR Mutations in Exon 19 and 21 From Brain Metastasis;Academic Radiology;2024-04
2. Characterization of immunogenic cell death regulators predicts survival and immunotherapy response in lung adenocarcinoma;Life Sciences;2024-02
3. Coexistence of Rosai-Dorfman disease and Hodgkin’s lymphoma in a patient with cervical lymphadenopathy;BMJ Case Reports;2023-09
4. Carcinoma de células grandes de pulmón con inmunofenotipo nulo: reporte de caso y revisión breve de la literatura;Revista Española de Patología;2023-07
5. High TLX1 expression correlates with poor prognosis and immune infiltrates in patients with lung adenocarcinoma;Current Molecular Medicine;2023-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3